Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Merrygold M is a multi-ingredient finished pharmaceutical formulation developed by Gynavista for the treatment of male infertility and the enhancement of male sexual health. Marketed as a "Herbal For Men Libido" product, it combines several traditional herbal extracts with essential minerals and vitamins. The formulation includes Ashwagandha, Horny Goat Weed, Tribulus Terrestris, Yohimbine, Mucuna Pruriens, Safed Musli, and Shilajit, along with Magnesium, Zinc, and Vitamin B6. These ingredients work synergistically to improve libido, stamina, and reproductive vitality. Specifically, Yohimbine acts as an alpha-2 adrenergic receptor antagonist to support erectile function, while Horny Goat Weed provides icariin, a natural PDE5 inhibitor. Other components like Ashwagandha and Mucuna Pruriens serve as adaptogens and dopamine precursors to support hormonal balance and reduce stress-related infertility. Merrygold M is commercially available in India as an oral tablet.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Merrygold M.